Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Human serum albumin

SKU: orb2563753

Description

Human Serum Albumin (HSA) is a key plasma protein that acts as a major endogenous inhibitor of amyloid-β aggregation, relevant to Alzheimer's disease research. It is widely utilized in vitro as a carrier protein in cell culture, drug delivery studies, and as a stabilizer in immunoassays and biopreservation.

Research Area

Immunology & Inflammation, Neuroscience, Protein Biochemistry, Signal Transduction

Images & Validation

Key Properties

CAS Number70024-90-7
TargetNF-κB,Beta Amyloid,NO Synthase
SolubilityH2O:100 mg/mL

Bioactivity

In Vivo
In a study on male Swiss mouse models, Human serum albumin administered intravenously at a dose of 10 ml/kg once at 1 hour and once at 5 hours effectively mitigated the oxidative stress and nitric oxide overproduction induced by lipopolysaccharide (LPS, 50 mg/kg via intraperitoneal injection). The treatment successfully inhibited iNOS expression and formation of peroxynitrite (ONOO−), reduced the upregulation of NF-κB, and prevented the decline in vascular response to phenylephrine, muscle tone, and endothelial function caused by endotoxin.
In Vitro
Human serum albumin (HSA) at a concentration of 5 μM for 0-90 minutes can bind with Glycerol monolaurate (GML), with a dissociation constant (K d) of 1.4 μM, and it serves to protect T cell function by preventing GML from inhibiting human T cells. HSA at concentrations of 0.01, 0.05, and 0.1 μM over 0-24 hours can mitigate the GML-induced phosphorylation of AKT at threonine 308 and serine 473, as well as the formation of LAT, PLC-γ1, and AKT microclusters, while restoring the production of IFN-γ, IL-2, IL-10, and TNF-α in GML-treated cells. Western Blot analysis in activated peripheral blood T cells at a 0.05 μM concentration with incubation times of 0, 2, 5, and 15 minutes showed that it affected GML's ability to inhibit AKT phosphorylation. RT-PCR studies, using activated peripheral blood T cells with concentrations of 0.1, 0.05, and 0.005 μM over 24 hours, demonstrated the restoration of IFN-γ, IL-2, IL-10, and TNF-α production in GML-treated cells.

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

HSA

Similar Products

  • Human Ischemia Modified Albumin (IMA) ELISA Kit [orb779226]

    Human

    468.75-30000 ng/mL

    156.9 ng/mL

    48 T, 96 T
  • Human Glycated Albumin (GA) ELISA Kit [orb782227]

    Human

    15.63-1000 pmol/mL

    5.03 pmol/mL

    48 T, 96 T
  • Human Anti-Albumin Antibody (Anti-ALB) ELISA Kit [orb781668]

    Human

    3.13-200 ng/mL

    1.3 ng/mL

    96 T, 48 T
  • Human Lipocalin 1 (LCN1) ELISA Kit [orb775640]

    Human

    1.57-100 ng/mL

    0.63 ng/mL

    48 T, 96 T
  • Human Afamin (AFM) ELISA Kit [orb776872]

    Human

    3.13-200 ng/mL

    1.54 ng/mL

    48 T, 96 T
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Protocol Information

Available Sizes

Select a size below

50 mg
$ 70.00
100 mg
$ 90.00
500 mg
$ 170.00
1 g
$ 230.00
DispatchUsually dispatched within 5-10 working days
Bulk Enquiry